Blue Water Vaccines: Funding, Investors & Team (Oct 2026)
Blue Water Vaccines, Inc. is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. Headquartered in Cincinnati, OH, the company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children's Hospital Medical Center (CCHMC), and St. Jude Children's Hospital. The company is developing a universal flu vaccine that will provide protection from all virulent strains and a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children. Additionally, Blue Water Vaccines has licensed a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria among others.
Blue Water Vaccines has raised $8.0M across 1 funding round on record, the most recent a Post-IPO Equity of $8.0M announced in Apr 2022.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Blue Water Vaccines Company Profile and Key Stats
Latest funding round on record: Apr 2022.
Blue Water Vaccines Funding Rounds
Blue Water Vaccines Founders and Leadership Team
Contact details for the Blue Water Vaccines team: 1 of 1 has an email address on file.
Start 14-day free trial →Blue Water Vaccines Funding Compared to Other Biotechnology Startups
Blue Water Vaccines' latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Blue Water Vaccines in Biotechnology and Cincinnati
Companies Similar to Blue Water Vaccines
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Blue Water Vaccines Funding FAQs
What does Blue Water Vaccines do?
Blue Water Vaccines, Inc. is a biopharmaceutical company focused on developing transformational vaccines to address significant health challenges globally. Headquartered in Cincinnati, OH, the company holds the rights to proprietary technology developed at the University of Oxford, Cincinnati Children's Hospital Medical Center (CCHMC), and St. Jude Children's Hospital. The company is developing a universal flu vaccine that will provide protection from all virulent strains and a Streptococcus pneumoniae (pneumococcus) vaccine candidate, designed to specifically prevent the highly infectious middle ear infections, known as Acute Otitis Media (AOM), in children. Additionally, Blue Water Vaccines has licensed a novel norovirus (NoV) S&P nanoparticle versatile virus-like particle (VLP) vaccine platform from CCHMC to develop vaccines for multiple infectious diseases, including norovirus/rotavirus and malaria among others.
How much funding has Blue Water Vaccines raised?
Blue Water Vaccines has raised $8.0M across 1 round on record. The most recent is a Post-IPO Equity of $8.0M announced in Apr 2022.
When did Blue Water Vaccines last raise funding?
Blue Water Vaccines' most recent funding round on record is a Post-IPO Equity of $8.0M, announced in Apr 2022.
Who is the CEO of Blue Water Vaccines?
Joseph Hernandez is listed as CEO at Blue Water Vaccines.
Where is Blue Water Vaccines headquartered?
Blue Water Vaccines is based in Cincinnati, Ohio, United States.
How many employees does Blue Water Vaccines have?
Blue Water Vaccines is in the 1-10 employee band.
How does Blue Water Vaccines' funding compare to other Biotechnology startups?
Blue Water Vaccines' latest round of $8.0M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Blue Water Vaccines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Blue Water Vaccines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.